康拓医疗:2024年报净利润0.88亿 同比增长15.79%

Financial Performance - The company reported a basic earnings per share of 1.09 yuan for 2024, an increase of 17.2% compared to 0.93 yuan in 2023 [1] - The net profit for 2024 was 0.88 billion yuan, reflecting a 15.79% increase from 0.76 billion yuan in 2023 [1] - The operating revenue reached 3.22 billion yuan, up 17.09% from 2.75 billion yuan in the previous year [1] - The return on equity (ROE) improved to 14.37% in 2024, compared to 13.46% in 2023, marking a 6.76% increase [1] Shareholder Structure - The top ten unrestricted shareholders collectively hold 58.03 million shares, accounting for 71.44% of the circulating shares, with a change of 501,700 shares from the previous period [2] - The largest shareholder, Hu Liren, holds 39.55 million shares, representing 48.68% of the total share capital, with no change [2] - New entrants among the top shareholders include Industrial Bank Co., Ltd. - Fortune Xinyuan Preferred 12-Month Holding Mixed Securities Investment Fund, holding 1.61 million shares [2] Dividend Distribution - No specific information regarding the dividend distribution plan was provided in the documents [3]